Chimerix (CMRX) Posts Q1 Loss of 39c/Share

Chimerix (NASDAQ: CMRX) reported Q1 EPS of ($0.39), $0.03 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $780 thousand versus the consensus estimate of $850 thousand.

For earnings history and earnings-related data on Chimerix (CMRX) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Pfizer reaffirms 2026 guidance after CFO transition news
• Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight